326030 — SK Biopharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩10tn
- KR₩10tn
- KR₩548bn
Annual cashflow statement for SK Biopharmaceuticals Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -247,414 | 64,846 | -139,431 | -35,379 | 226,973 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 15,110 | -95,838 | 35,848 | 5,643 | -105,692 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 7,465 | -73,521 | -69,321 | -79,782 | -43,809 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -213,980 | -92,872 | -159,920 | -94,201 | 94,900 |
| Capital Expenditures | -14,336 | -5,992 | -5,961 | -3,249 | -13,424 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -304,394 | 264,963 | -89,753 | 228,522 | 2,484 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -318,730 | 258,971 | -95,714 | 225,273 | -10,941 |
| Financing Cash Flow Items | — | 181 | -1,360 | 12,198 | 0.377 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 540,902 | -4,646 | 134,914 | 6,623 | -4,498 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8,192 | 166,589 | -121,863 | 135,640 | 83,107 |